FILE - This Wednesday, Dec. 23, 2020 file photo shows a vial of the Moderna COVID-19 vaccine in the first round of staff vaccinations at a hospital in Denver. U.S. health advisers are debating if millions of Americans who received Moderna vaccinations should get a booster shot -- this time, using half the original dose. Already millions who got their initial Pfizer shots at least six months ago are getting a booster of that brand. On Thursday, Oct. 14, 2021, advisers to the Food and Drug Administration evaluated the evidence that Moderna boosters should be offered, too -- and on Friday, they’ll tackle the same question for those who got Johnson & Johnson’s vaccine. (AP Photo/David Zalubowski, File)
(AP)–A panel of U.S. health advisers has endorsed booster shots for Moderna’s COVID-19 vaccine. The advisers to the Food and Drug Administration voted Thursday to recommend a lower-dose booster shot for seniors and other high-risk groups.
Already millions who got their initial Pfizer shots at least six months ago are getting a booster of that brand. The FDA panel will discuss booster shots of Johnson & Johnson vaccine on Friday.
Final decisions are expected next week. U.S. officials stress that the priority is to get shots to the 66 million unvaccinated Americans who are eligible.
In Chile, Haitians Grow Weary Of Waiting, Eye Journey To US